Menstrual Cycle Hormone Relaxin and ACL Injuries in Female Athletes: A Systematic Review
- PMID: 38919370
- PMCID: PMC11195904
Menstrual Cycle Hormone Relaxin and ACL Injuries in Female Athletes: A Systematic Review
Abstract
Background: Female athletes are at increased risk for anterior cruciate ligament (ACL) injuries. The influence of hormonal variation on female ACL injury risk remains ill-defined. Recent data suggests that the collagen-degrading menstrual hormone relaxin may cyclically impact female ACL tissue quality. This review aims to identify any correlation between menstrual relaxin peaks and rates of female ACL injury.
Methods: A systematic review was performed, utilizing the MEDLINE, EMBASE, and CINAHL databases. Included studies had to directly address relaxin/female ACL interactions. The primary outcome variable was relaxin proteolysis of the ACL, at cellular, tissue, joint, and whole-organism levels. The secondary outcome variable was any discussed method of moderating relaxin levels, and the clinical results if available.
Results: AllThe numerous relaxin receptors on female ACLs upregulate local collagenolysis and suppress local collagen production. Peak serum relaxin concentrations (SRC) occur during menstrual cycle days 21-24; a time phase associated with greater risk of ACL injury. Oral contraceptives (OCPs) reduce SRC, with a potential ACLprotective effect.
Conclusion: A reasonable correlative and plausible causative relationship exists between peak relaxin levels and increased risk of ACL injury in females, and further investigation is warranted. Level of Evidence: III.
Keywords: acl rupture; female athlete physiology; injury prevention; sex-based risk factors; sports medicine.
Copyright © The Iowa Orthopaedic Journal 2024.
Conflict of interest statement
Disclosures: EAP and AMM declare no competing interests. KRD reports educational support from Wardlow Enterprises, other support from Smith & Nephew, and other support from Stryker; outside the submitted work. BWW reports consulting fees, royalty or license fees, and other support from Linvatec Corp; outside the submitted work. RWW reports personal fees from Smith & Nephew, personal fees from Medical Device Business Systems, personal fees from Linvatec Corp, non-financial support and other support from Smith & Nephew, other support from Arthrex, and other support from Wardlow Enterprises; outside the submitted work.
Figures



References
-
- Bryant-Greenwood GD, Mercado-Simmen R, Yamamoto SY, Arakaki RF, Uchima FD, Greenwood FC. Relaxin receptors and a study of the physiological roles of relaxin. Advances in experimental medicine and biology. 1982;143:289–314. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous